Midatech Pharma PLC Midatech presenting at the Shares/AJ Bell Webinar
24 November 2021 - 06:00PM
RNS Non-Regulatory
TIDMMTPH
Midatech Pharma PLC
24 November 2021
REACH
24 November 2021
Midatech Pharma PLC
("Midatech" or the "Company")
Midatech presenting at the Shares and AJ Bell Webinar
Midatech Pharma PLC (AIM: MTPH; Nasdaq: MTP), a drug delivery
technology company focused on improving the bio-delivery and
biodistribution of medicines, is pleased to announce that the
Company's CEO and CFO, Stephen Stamp, will be presenting at the
Shares and AJ Bell investor webinar on Wednesday 1 December 2021 at
approximately 19.20 GMT.
The Shares and AJ Bell evening webinars are an opportunity for
senior board directors from quoted companies to make a presentation
about their company and update existing and potential investors on
their business plans.
Shareholders and potential investors can register to join the
webinar for free at:
https://www.sharesmagazine.co.uk/events/event/shares-investor-webinar-011221
For more information, please contact:
Midatech Pharma PLC
Stephen Stamp, CEO, CFO
Tel: +44 (0)29 2048 0180
www.midatechpharma.com
IFC Advisory Limited (Financial PR and UK Investor Relations)
Tim Metcalfe / Graham Herring
Tel: +44 (0)20 3934 6630
Email: midatech@investor-focus.co.uk
About Midatech Pharma PLC
Midatech Pharma PLC (dual listed on LSE AIM: MTPH; and NASDAQ:
MTP) is a drug delivery technology company focused on improving
the bio-delivery and bio-distribution of medicines. The Company
combines approved and development medications with its proprietary
and innovative drug delivery technologies to provide compelling
products that have the potential to powerfully impact the
lives of patients.
The Company has developed three in-house technology platforms,
each with its own unique mechanism to improve delivery of
medications to sites of disease. All of the Company's technologies
have successfully entered human use in the clinic, providing
important validation of the potential for each platform:
* Q-Sphera(TM) platform: a disruptive micro-technology
used for sustained release to prolong and control the
release of therapeutics over an extended period of
time (from weeks to months).
* MidaSolve(TM) platform: an innovative nanotechnology
used to dissolve insoluble drugs so that they can be
administered in liquid form directly and locally into
tumours.
* MidaCore(TM) platform: a leading-edge nanotechnology
used for targeting medications to sites of disease.
The platform nature of the technologies offers the potential
to develop multiple drug assets rather than being reliant
on a limited number of programmes. Midatech's technologies
are supported by 36 patent families including 120 granted
patents and an additional 70 patent applications. Midatech's
headquarters and R&D facility is in Cardiff, UK. For more
information please visit www.midatechpharma.com
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAPPGQGGUPGGCW
(END) Dow Jones Newswires
November 24, 2021 02:00 ET (07:00 GMT)
Midatech Pharma (LSE:MTPH)
Historical Stock Chart
From Feb 2024 to Mar 2024
Midatech Pharma (LSE:MTPH)
Historical Stock Chart
From Mar 2023 to Mar 2024